.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Entacapone - Generic Drug Details

« Back to Dashboard
Entacapone is the generic ingredient in two branded drugs marketed by Aurobindo Pharma Ltd, Wockhardt Ltd, Sun Pharma Global, Mylan Pharms Inc, and Orion Pharma, and is included in five NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

This ingredient has forty-four patent family members in thirty-seven countries.

There are nineteen drug master file entries for entacapone. Eight suppliers are listed for this compound.

Summary for Generic Name: entacapone

Tradenames:2
Patents:1
Applicants:5
NDAs:5
Drug Master File Entries: see list19
Suppliers / Packaging: see list8
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: entacapone

Clinical Trials for: entacapone

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt Ltd
ENTACAPONE
entacapone
TABLET;ORAL078941-001Aug 16, 2012RXNo
Mylan Pharms Inc
ENTACAPONE
entacapone
TABLET;ORAL202394-001May 13, 2013RXNo
Sun Pharma Global
ENTACAPONE
entacapone
TABLET;ORAL090690-001Jul 16, 2012RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: entacapone

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 19994,963,590<disabled>
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 19995,446,194<disabled>
Orion Pharma
COMTAN
entacapone
TABLET;ORAL020796-001Oct 19, 19995,135,950<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: entacapone

Country Document Number Estimated Expiration
Germany69913714<disabled in preview>
China1319005<disabled in preview>
Turkey200100752<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc